Pete November

Pete brings extensive experience in non-profit leadership, especially strategic planning, and has helped organizations navigate periods of significant change and expansion. Prior to joining The Possible Project, Pete worked as a consultant to support operations and key initiatives across multiple clients. Previously, Pete served as Chief Strategy Officer at iMentor, COO at the Center for Time and Learning, and as Regional Vice President at City Year.

Laurence Reid, Ph.D

Laurence is the CEO at Warp Drive Bio LLC. Prior to that he worked as the Senior Vice President and Chief Business Officer at Alnylam Pharmaceuticals. Before his position at Alnylam, Laurence was the Chief Business Officer at Ensemble Discovery, where he led the company’s strategic planning, product strategy, and corporate development efforts. During 2004-2005, Laurence worked as a founder of two startup companies in the fields of stem cell therapeutics and inflammation. Laurence previously spent ten years at Millennium Pharmaceuticals in a range of general management and business development positions. From 2001-2003, Laurence served as General Manager of Millennium UK with responsibility for Millennium’s European operations and as spokesperson to the European investor and media communities. Previously (1998-2001), he had been the Vice President of Business Development and Strategic Planning for the company’s predictive medicine efforts.

Steven Singer

Steven Singer has more than three decades of experience as a corporate attorney who has represented clients in a wide range of transactions. He has advised numerous public and private companies in the life sciences industry, focusing on joint ventures and strategic alliances, corporate and securities law, public offerings and venture capital transactions. Mr. Singer is consistently recognized in the areas of corporate and life sciences for successfully handling complex deals and collaborations in the technology transactions and licensing sector.

Practice

Mr. Singer has focused his practice in the life sciences industry for nearly three decades. He has served as counsel for public and private companies in the life sciences sector, including biotechnology, medical device and pharmaceutical companies. His practice focuses on joint ventures and strategic alliances, corporate and securities laws, public offerings and venture capital transactions.

Mr. Singer has worked with the following public company clients, among others: Achillion, Agios, Aveo, Catabasis, Cerulean, Curis, Editas, Infinity, Karyopharm and Syros. Representative private company clients include Ataxion, Constellation, Cydan, Denali, Fulcrum, Visterra and X-Chem. Mr. Singer has also worked with pharmaceutical companies, including Becton Dickinson, Bristol Myers Squibb, Novartis and Wyeth.

Mr. Singer has also worked with New York-based medical and academic institutions in the establishment and operation of an independent, nonprofit genome sequencing center and the Tri-Institutional Therapeutics Discovery Institute.

Nancy Jones

I am deeply driven by The Possible Project’s commitment to ensure each of our students believes anything is possible – and to help them acquire the skills and mindsets to get achieve those things. My time is spent in the community with thoughtful organizations and people – like you – who care about Greater Boston’s young people.

Ask me about how to get involved in our work, the possibilities are many.

I am a mom first, raising children – who are now pretty amazing adults – in urban environs I, and they, experienced firsthand what can happen when students do not have the necessary skills, supports and resources to thrive. It is why for more than 20 years I’ve worked on K-12 education reforms; been president of the PTA; and, raised money to help fill some of the gaps.

When I am not working to help some of our most-deserving youth, you can likely find me in the kitchen most often working on a soup or pie.